Investigation of Q Angle in Osteoporosis Patients

Investigation of Q Angle and Related Factors in Osteoporosis Patients

Osteoporosis (OP) is a bone disease characterized by reduced bone density and deterioration of bone tissue, leading to an increased risk of fractures. There are no studies evaluating Q angle in patients with OP and Osteopenia (OPN) in the literature. Therefore, the aim of this study was to examine the Q angle in patients diagnosed with OP and OPN and to compare it with patients diagnosed with OA. The study will be carried out by measuring the Q angle measurement with a goniometer. Pain assessment will be done with Visual Analog Scale (VAS). Lower extremity muscle strength will be assessed with the Medical Research Council (MRC) Scale. Foot posture will be assessed with the Foot Posture Index (FPI).

Study Overview

• Status: Recruiting
• Conditions: Osteoporosis
• Intervention / Treatment: Other: Patients with osteoporosis group; Other: Patients with osteoarthritis group

Detailed Description

Osteoporosis (OP) is a bone disease characterized by reduced bone density and deterioration of bone tissue, leading to an increased risk of fractures. According to Calis et al; it was found that patients with hip fracture had a significantly higher Q angle compared to patients without hip fracture. According to You et al; contraction of the quadriceps muscles corrects the Q angle, therefore sports that use high amounts of quadriceps (strength) training are associated with lower Q angles due to the pulling effect of the quadriceps muscle. There are no studies evaluating Q angle in patients with OP and Osteopenia (OPN) in the literature. Therefore, the aim of this study was to examine the Q angle in patients diagnosed with OP and OPN and to compare it with patients diagnosed with OA. The study will be carried out by measuring the Q angle measurement with a goniometer. Pain assessment will be done with Visual Analog Scale (VAS). Lower extremity muscle strength will be assessed with the Medical Research Council (MRC) Scale. Foot posture will be assessed with the Foot Posture Index (FPI).

• Study Type: Observational
• Enrollment (Estimated): 30

Contacts and Locations

Study Locations

• Turkey
  • Elazığ, Turkey, 23100
    • Recruiting
    • Songul Baglan Yentur
    • Contact: Songul Baglan Yentur; Phone Number: 04242370000; Email: songulbaglan23@hotmail.com
    • Contact: Songul Baglan Yentur; Email: songulbaglan23@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Patients who are willing to participate in the study, being between the ages of 40-65 will be included in the study. Patients who have patellofemoral abnormalities during examination, acute traumatic patellofemoral dislocations, surgical revision around the knee, history of any previous lower extremity surgery and serious trauma will be excluded from the study.

Description

Inclusion Criteria:

• Be willing to participate in the study.
• Being between the ages of 40-65.
• Being a woman.

Exclusion Criteria:

• Patellofemoral abnormalities during examination.
• Acute traumatic patellofemoral dislocations
• Surgical revision around the knee
• History of any previous lower extremity surgery
• Serious trauma

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients with osteoporosis group; Osteoporosis patients will be evaluated in terms of pain, foot posture, Q angle and lower limbs muscle strength.	Other: Patients with osteoporosis group; Pain, Q angle, muscle strength and foot posture will be evaluated.
Patients with osteoarthritis group; Osteoarthritis patients will be evaluated in terms of pain, foot posture, Q angle and lower limbs muscle strength.	Other: Patients with osteoarthritis group; Osteoarthritis patients will be evaluated in terms of pain, foot posture, Q angle and lower limbs muscle strength.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Q angle assessment	Q angle will be evaluated with goniometer.	1 minute

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain assessment	Pain assessment will be done with the Visual Analog Scale (VAS). This measurement is performed with a chart in which no pain is written on one end and very severe pain is written on the other end.	1 minute
Muscle strength assessment	Lower extremity muscle strength will be assessed with the Medical Research Council (MRC) Scale. Muscle strength is graded on a scale of 0 to 5 according to muscle tone and ability to resist the force of gravity.	2 minutes
Foot posture assessment	Foot posture will be evaluated with the Foot Posture Index (FPI). API is an easy-to-apply, valid and reliable method that provides information about the degree of pronation and supination of the foot with a single numerical result and evaluates the foot in a multidimensional and comprehensive manner.	1 minute

Collaborators and Investigators

• Sponsor: Firat University

Study record dates

Study Major Dates

• Study Start (Estimated): June 20, 2024
• Primary Completion (Estimated): July 20, 2024
• Study Completion (Estimated): July 30, 2024

Study Registration Dates

• First Submitted: June 14, 2024
• First Submitted That Met QC Criteria: June 24, 2024
• First Posted (Actual): June 26, 2024

Study Record Updates

• Last Update Posted (Actual): June 26, 2024
• Last Update Submitted That Met QC Criteria: June 24, 2024
• Last Verified: June 1, 2024

More Information

Terms related to this study

• Keywords: Osteoporosis; Osteopenia; Q angle
• Additional Relevant MeSH Terms: Metabolic Diseases; Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic; Osteoporosis
• Other Study ID Numbers: 2024/07-33

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No